Ethyl 6-chloropyridazine-4-carboxylate

Catalog No. :
ACUDSK381
CAS No. :
612834-90-9
Molecular Formula :
C7H7ClN2O2
Molecular Weight :
186.60

IUPAC Name:ethyl 6-chloropyridazine-4-carboxylate

Ethyl 6-chloropyridazine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$67.00Login to see priceIn stockInquiry
1g95%$135.00Login to see priceIn stockInquiry
5g95%$476.00Login to see priceIn stockInquiry
10g95%$901.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 6-chloropyridazine-4-carboxylate
IUPAC Nameethyl 6-chloropyridazine-4-carboxylate
MDL No.MFCD18205955
Molecular FormulaC7H7ClN2O2
Molecular Weight186.60
SMILESO=C(C1=CC(Cl)=NN=C1)OCC
InChI KeyDZSYDSVXAOQGNB-UHFFFAOYSA-N
Synonym6-Chloro-pyridazine-4-carboxylic acid ethyl ester;Ethyl 6-chloropyridazine-4-carboxylate;4-Pyridazinecarboxylic acid, 6-chloro-, ethyl ester;6-Chloro-pyridazine-4-carboxylic acid ethyl este;ETHYL 6-CHL0R0PYRIDAZINE-4- CARBOXYLATE
CAS No.612834-90-9
PubChem CID72206828

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACUDSK381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRQSF562 route compound structure diagram
    ACRQSF5621256794-24-7 In Stock
  4. Then
  5. ACUDSK381 route product structure diagram
    ACUDSK381612834-90-9 In Stock
Inquiry

2. ACUDSK381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACRQSF562 route compound structure diagram
    ACRQSF5621256794-24-7 In Stock
  4. Then
  5. ACUDSK381 route product structure diagram
    ACUDSK381612834-90-9 In Stock
Inquiry

Comments (0)